Vascular changes in the diabetic kidney: Effects of ACE inhibition

被引:20
作者
Vranes, D
Dilley, RJ
Cooper, ME
机构
[1] Department of Medicine, University of Melbourne, Heidelberg Hospital, West Heidelberg
[2] Morphology Laboratory, Baker Medical Research Institute, Prahran
关键词
D O I
10.1016/1056-8727(95)80026-B
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of angiotensin-converting enzyme (ACE) inhibition with perindopril on renal vascular structure were studied in control and streptozotocin diabetic male Sprague-Dawley rats after 3 weeks. After kidneys were perfusion-fixed at systolic blood pressure, morphometric analysis of vascular structural changes in the media of the renal vasculature at the cortico-medullary junction was performed. Vascular hypertrophy was present in the diabetic vessels, as assessed by an increase in medial cross-sectional area for a given lumen size. This relative increase in medial area was prevented by perindopril treatment, consistent with an antitrophic effect on diabetic kidney vessels by ACE inhibition. The diabetic kidney had an increased proportion of small vessels less than 50 mu m diameter at the cortico-medullary junction, perhaps representing diabetes induced angiogenesis. This subpopulation of vessels was reduced in number after perindopril treatment. Our data support a role for increased activity of angiotensin converting enzyme as a mechanism for vascular hypertrophy, which may be involved in the pathogenesis of diabetic vasculopathy and nephropathy.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 29 条
[1]  
ALLEN TJ, 1990, DIABETES, V38, P1182
[2]   RENAL RENIN-ANGIOTENSIN SYSTEM IN DIABETES - FUNCTIONAL, IMMUNOHISTOCHEMICAL, AND MOLECULAR BIOLOGICAL CORRELATIONS [J].
ANDERSON, S ;
JUNG, FF ;
INGELFINGER, JR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :F477-F486
[3]   ENDOTHELIUM-DEPENDENT RELAXATIONS ARE AUGMENTED IN RATS CHRONICALLY TREATED WITH THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ENALAPRIL [J].
BOSSALLER, C ;
AUCHSCHWELK, W ;
WEBER, F ;
GOTZE, S ;
GRAFE, M ;
GRAF, K ;
FLECK, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S91-S95
[4]   VALIDATION IN AWAKE RATS OF A TAIL-CUFF METHOD FOR MEASURING SYSTOLIC PRESSURE [J].
BUNAG, RD .
JOURNAL OF APPLIED PHYSIOLOGY, 1973, 34 (02) :279-282
[5]   DIABETES-ASSOCIATED MESENTERIC VASCULAR HYPERTROPHY IS ATTENUATED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITION [J].
COOPER, ME ;
RUMBLE, J ;
KOMERS, R ;
HECHENG, D ;
JANDELEIT, K ;
SHEUNGTO, C .
DIABETES, 1994, 43 (10) :1221-1228
[6]   NEPHROPATHY IN MODEL COMBINING GENETIC-HYPERTENSION WITH EXPERIMENTAL DIABETES - ENALAPRIL VERSUS HYDRALAZINE AND METOPROLOL THERAPY [J].
COOPER, ME ;
ALLEN, TJ ;
OBRIEN, RC ;
PAPAZOGLOU, D ;
CLARKE, BE ;
JERUMS, G ;
DOYLE, AE .
DIABETES, 1990, 39 (12) :1575-1579
[7]   ROLE OF KININS AND NITRIC-OXIDE IN THE EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON NEOINTIMA FORMATION [J].
FARHY, RD ;
CARRETERO, OA ;
HO, KL ;
SCICLI, AG .
CIRCULATION RESEARCH, 1993, 72 (06) :1202-1210
[8]   KIDNEY-DISEASE OF DIABETES-MELLITUS - NIDDK INITIATIVES FOR THE COMPREHENSIVE STUDY OF ITS NATURAL-HISTORY, PATHOGENESIS, AND PREVENTION [J].
FITZSIMMONS, SC ;
AGODOA, L ;
STRIKER, L ;
CONTI, F ;
STRIKER, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (01) :7-10
[9]  
GRAFE M, 1993, AM J PHYSIOL, V264, pH149
[10]   DEVELOPMENT OF GLOMERULAR-LESIONS IN EXPERIMENTAL LONG-TERM DIABETES IN THE RAT [J].
HIROSE, K ;
OSTERBY, R ;
NOZAWA, M ;
GUNDERSEN, HJG .
KIDNEY INTERNATIONAL, 1982, 21 (05) :689-695